News-Papers
Testimonial
Video Gallery
Powered by Phoca Gallery
Search
Follow us...
Latest
- Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
- Molecular aspects of melatonin (MLT)-mediated therapeutic effects
- Breast Cancer and Prolactin - New Mechanisms and Models
- Melatonin as an anti-inflammatory agent in radiotherapy
- Somatostatin Radioligand Therapy of Breast Cancer: A Target of Opportunity
- Interactions of melatonin with various signaling pathways: implications for cancer therapy
- Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-hodgkin lymphoma: A retrospective analysis at a single institution
- Melatonin and vitamin D as potential synergistic adjuvants for cancer therapy (Review)
- Hybrid Somatostatin Receptor PET/MRI of the Head and Neck
- Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
- Updated perspectives on vitamin D deficiency, screening, supplementation and clinical guidance
- Melatonin: an inhibitor of breast cancer
- All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
- Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice
- Effect of oral melatonin on sleep quality, fatigue, and caregiver sleep perception in patients with head and neck cancer: A randomized double-blind placebo-controlled trial
- Mechanisms Underlying Tumor Suppressive Properties of Melatonin
- Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis
- Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer